Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Virpax? Pharmaceuticals Inc., corporate

Virpax? Pharmaceuticals Inc.,

23.02.2021 - 14:03:55

Virpax Pharmaceuticals Inc.: Virpax Begins IND Enabling Studies of Envelta

484-880-4588

Or

Betsy Brod Affinity Growth Advisorsbetsy.brod@affinitygrowth.com 212-661-2231

SOURCE: Virpax Pharmaceuticals

23.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Virpax(R) Pharmaceuticals Inc. 1554 Paoli Pike PA 19380 West Chester

United States Phone: 484.880.4588 E-mail: info@virpaxpharma.com EQS News ID: 1170287 ? End of News DGAP News Service

1170287??23.02.2021?

@ dgap.de